The Conversation (0)
Bloomberg reported that the world’s biggest maker of HIV drug treatments, Gilead Sciences Inc. (NASDAQ:GILD), is still looking to buy more blood cancer drugs after spending $1.2 billion on such drugs in the last two years.
Bloomberg reported that the world’s biggest maker of HIV drug treatments, Gilead Sciences Inc. (NASDAQ:GILD), is still looking to buy more blood cancer drugs after spending $1.2 billion on such drugs in the last two years.
As quoted in the market news:
Treatment for leukemia and other blood cancers is one of the fastest growing markets for cancer drugs. Gilead’s recent string of four deals is intended to tap into that market and set the stage for the company’s growth for years.
Outlook Reports world
Featured Life Science Investing Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES